Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
Title : Multitarget molecule,PTUPB, to treat diabetic nephropathy in rats - Hye_2021_Br.J.Pharmacol_178_4468 |
Author(s) : Hye Khan MA , Hwang SH , Barnett SD , Stavniichuk A , Jankiewicz WK , Hammock BD , Imig JD |
Ref : British Journal of Pharmacology , 178 :4468 , 2021 |
Abstract : Hye_2021_Br.J.Pharmacol_178_4468 |
ESTHER : Hye_2021_Br.J.Pharmacol_178_4468 |
PubMedSearch : Hye_2021_Br.J.Pharmacol_178_4468 |
PubMedID: 34255857 |
Title : Dual Soluble Epoxide Hydrolase Inhibitor\/PPAR-gamma Agonist Attenuates Renal Fibrosis - Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472 |
Author(s) : Stavniichuk A , Hye Khan MA , Yeboah MM , Chesnik MA , Jankiewicz WK , Hartmann M , Blocher R , Kircher T , Savchuk O , Proschak E , Imig JD |
Ref : Prostaglandins Other Lipid Mediat , :106472 , 2020 |
Abstract : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472 |
ESTHER : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472 |
PubMedSearch : Stavniichuk_2020_Prostaglandins.Other.Lipid.Mediat__106472 |
PubMedID: 32569747 |
Title : A dual farnesoid X receptor\/soluble epoxide hydrolase modulator treats non-alcoholic steatohepatitis in mice - Hye_2019_Biochem.Pharmacol_166_212 |
Author(s) : Hye Khan MA , Schmidt J , Stavniichuk A , Imig JD , Merk D |
Ref : Biochemical Pharmacology , 166 :212 , 2019 |
Abstract : Hye_2019_Biochem.Pharmacol_166_212 |
ESTHER : Hye_2019_Biochem.Pharmacol_166_212 |
PubMedSearch : Hye_2019_Biochem.Pharmacol_166_212 |
PubMedID: 31129048 |